Xstrahl Appoints Dr. Richard Shaffer as Medical Director

ATLANTA, Sept. 24, 2020 /PRNewswire-PRWeb/ -- Xstrahl, the leader in superficial radiation therapy and research systems for cancer, announced today that it has appointed Richard Shaffer, FRCR, as medical director. Dr. Shaffer will help drive the clinical application of superficial and orthovoltage radiation therapy for skin cancer and benign diseases.

"As skin cancer incidence continues to rise, we want to we further support clinicians in the use of low-dose x-ray radiation as part of a comprehensive treatment plan," said Adrian Treverton, CEO of Xstrahl. "Dr. Shaffer's leadership in this area is important in not only increasing patient access to radiation therapy for NMSC but in also supporting its safe and effective use for other benign indications," he added.

Dr. Shaffer has deep expertise in radiotherapy development and innovation. He currently serves as the UK lead for skin cancer and benign radiotherapy for GenesisCare UK. Clinically, he has used radiotherapy and chemotherapy to treat brain tumors, prostate and bladder cancer, and skin cancer and has additional expertise in intracranial stereotactic radiotherapy and the use of radiation for benign conditions.

"I'm excited to join with Xstrahl to help extend the use of radiation therapy not only for skin cancer but also in treating benign disease, particularly for Dupuytren's and Ledderhose disease, Plantar Fasciitis, insertional Achilles tendinopathy, and keloid scarring," Dr. Shaffer stated. "By bringing both clinicians and industry together, we can help more patients receive this valuable treatment," he added.

Dr. Shaffer received his BSc in Biomedical Science from Manchester University and his MBBS from the University College of London Medical School. He formally served as chair of the radiotherapy strategy group in one of the NHS divisions prior to joining GenesisCare. Dr. Shaffer also currently serves as a consulting oncologist for BMIHealthcare and Cromwell Hospital.

# # #

For further information, please contact:
Kristie Amobi, VP of Marketing
Tel: +1-213-598-0236, e-mail: [email protected]
Time zone: PST: Pacific Standard Time

About Xstrahl
Xstrahl is a medical technology company that designs clinical and research systems to help eradicate cancer. For more than 20 years, Xstrahl has been shaping the development of superficial and orthovoltage therapies for cancer treatment and advancing preclinical research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide. Visit http://www.xstrahl.com to learn more.

SOURCE Xstrahl Inc